معلومات عن هذه الحلقة
Host: Shelina Ramnarine, PhD
Guest: David A. Johnson, MD, FACG, FACP
Guest: David A. Johnson, MD, FACG, FACP
Noninvasive colorectal cancer screening is only effective when abnormal results lead to timely, high-quality colonoscopy, but recent data shows significant gaps in follow-up. Join Dr. Shelina Ramnarine and Dr. David Johnson, Chief of Gastroenterology at Eastern Virginia Medical School at Old Dominion University, as they explore how primary acre clinicians can set expectations with patients, address barriers to follow-up, and strengthen workflows and care coordination to close the loop.
الإنجليزية
الولايات المتحدة
النص 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
البحث في الحلقات الماضية
البحث في الحلقات السابقة من Clinician's Roundtable.
حلقات أخرى في هذا البودكاست
What happens when vitreous hemorrhage (VH) secondary to non-tractional PDR doesn't clear on its own? And does preoperative anti-VEGF actually change surgical outcomes? Maria Berrocal, MD, speaks with Sumit Sharma, MD, about a retrospective case series of 360 patients who underwent vitrectomy for no…
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Mallik Greene, PhD
Guest: Jordan Karlitz, MD
A study published in the Journal of the National Comprehensive Cancer Network examined follow-up colonoscopy rates after positive stool-based colorectal cancer screening tests, finding nota…
Host: Shelina Ramnarine, PhD
Guest: Samuel Ubanyionwu, PharmD, EMBA
Accurate IV medication delivery depends on more than proper pump programming alone. It requires a comprehensive understanding of smart pump drug libraries, dose error reduction software (DERS), infusion mechanics, an…
Host: Brian P. McDonough, MD, FAAFP
Guest: David A. Lieberman, MD
Long-term effectiveness of colorectal cancer (CRC) screening depends on more than the performance of an individual test; it requires sustained adherence to recommended screening intervals and timely follow-up after abn…
Guest: Sayna Norouzi, MD
Because patients with IgA nephropathy (IgAN) often have few symptoms early in the disease course, communicating the importance of treatment and its impacts on long-term outcomes can be challenging. Join Dr. Sayna Norouzi as she discusses practical communication t…
إخلاء المسؤولية: البودكاست والأعمال الفنية المضمنة في هذه الصفحة مأخوذة من ReachMD، وهي مملوكة لمالكها وليست تابعة لشركة Listen Notes, Inc أو معتمدة منها.
تعديل
شكراً على مساعدتنا في الحفاظ على قاعدة بيانات البودكاست مُحدَّثة.
